BTG3 and breast carcinoma: Yu et al. [8] demonstrated that BTG3 expression was markedly reduced and its promoter region of BTG3 was hypermethylated without detectable mutations in the promoter and coding region in a wide variety of human breast cancer cell lines, suggesting that hypermethylation might be an important mechanism for inactivation of BTG3.